Aravis
Aravis SA is a private equity and venture capital firm that focuses on investments in startup companies.
Business Model:
Revenue: $3.1M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aravis Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
8,391,864Website Global Rank
318Website Monthly Traffic
Twitter Followers
Description
Aravis SA is a private equity and venture capital firm that focuses on investments in startup companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2004 | Symetis | Series A | 9.6M |
| 2/2014 | Synaffix BV | Series A | - |
| 3/2014 | Bird Rock Bio | Series B | 0 |
| 10/2003 | Miikana Therapeutics | Series A | 4.3M |
| 12/2009 | Evolva | Post-IPO Equity | 27.5M |
| 4/2005 | Ikaria | Series A | 10M |
| 9/2004 | Nura | Series A | 9.5M |
| 10/2009 | Evolva | Series B | 27.8M |
| 3/2005 | Borean Pharma | Series A | 0 |
| 9/2008 | ImVisioN Therapeutics | Series A | 4.1M |
| 12/2013 | Bellerophon Therapeutics | Series A | 0 |
| 8/2004 | Kalypsys | Series B | 29M |
| 9/2008 | Telormedix | Series A | 0 |
| 10/2002 | MerLion Pharma | Series A | 0 |
| 7/2009 | Symetis | Series B | 0 |
| 1/2009 | Synosia Therapeutics | Series B | 0 |
| 10/2010 | MerLion Pharma | Series C | 0 |
| 7/2006 | Ambrx | Series C | 52M |
| 1/2012 | Telormedix | Series B | 0 |
| 5/2009 | NovImmune | Venture Round | 0 |
| 10/2010 | Synosia Therapeutics | Series C | 0 |
| 8/2004 | Evolva | Series A | 14.8M |
| 12/2013 | Telormedix | Series B | 0 |
| 5/2009 | Bird Rock Bio | Series A | 13M |
| 10/2004 | Miikana Therapeutics | Series A | 3M |
| 12/2006 | Evolva | Series A | 10.3M |
| 2/2007 | Omeros | Series E | 0 |
| 6/2006 | NovImmune | Series B | 0 |
| 10/2008 | S*Bio | Venture Round | 26M |
| 4/2009 | Ambrx | Series D | 10M |
| 3/2014 | Bird Rock Bio | Series B | 0 |
| 2/2014 | Synaffix BV | Series A | - |
| 12/2013 | Bellerophon Therapeutics | Series A | 0 |
| 12/2013 | Telormedix | Series B | 0 |
| 1/2012 | Telormedix | Series B | 0 |
| 10/2010 | Synosia Therapeutics | Series C | 0 |
| 10/2010 | MerLion Pharma | Series C | 0 |
| 12/2009 | Evolva | Post-IPO Equity | 0 |
| 10/2009 | Evolva | Series B | 0 |
| 7/2009 | Symetis | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
